Aneuploidy selects for the acquisition of driver genes in breast cancer
Nature. 2026 Jul 8. doi: 10.1038/s41586-026-10752-9. Online ahead…
Exploring glucocorticoid receptor signalling in lymphangioleiomyomatosis
ERJ Open Res. 2026 Jun 29;12(3):01285-2025. doi: 10.1183/23120541.01285-2025.…
Long-term outcomes of sirolimus therapy in sporadic and tuberous sclerosis complex-associated lymphangioleiomyomatosis: a retrospective cohort study
Pol Arch Intern Med. 2026 Jun 12:17320. doi: 10.20452/pamw.17320.…
Advancing Cancer Prevention through Precision Prediction
Cancer Discov. 2026 Apr 1;16(4):647-650. doi: 10.1158/2159-8290.CD-25-2235.ABSTRACTEmerging…
A rise in double-strand breaks sensitizes tumors to oxidative metabolism inhibitors
Biomed Pharmacother. 2026 Mar 10;197:119184. doi: 10.1016/j.biopha.2026.119184.…
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
NPJ Genom Med. 2025 Nov 20;10(1):73. doi: 10.1038/s41525-025-00529-w.ABSTRACTNineteen…
Autocrine TGF-β signaling promotes cell motility and chemokine secretion in an angiomyolipoma-derived cell model of lymphangioleiomyomatosis
Am J Pathol. 2025 May 30:S0002-9440(25)00182-8. doi: 10.1016/j.ajpath.2025.04.019.…
Harnessing STING Signaling and Natural Killer Cells overcomes PARP Inhibitor Resistance in Homologous Recombination Deficient Breast Cancer
Cancer Res. 2025 Mar 11. doi: 10.1158/0008-5472.CAN-24-2531.…
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment
NAR Cancer. 2025 Mar 7;7(1):zcaf007. doi: 10.1093/narcan/zcaf007.…
A Novel RHEB Germline Variant Associated With Intellectual Disability and Epilepsy: Expanding the Spectrum of mTORopathies
Clin Genet. 2025 Feb 24. doi: 10.1111/cge.14734. Online ahead…
Cancer genetic counseling in Chile: Addressing barriers, confronting challenges, and seizing opportunities in an underserved Latin American Community
Genet Med Open. 2024 Oct 30;2(Suppl 2):101898. doi: 10.1016/j.gimo.2024.101898.…
Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity
Cell Death Discov. 2024 Sep 30;10(1):417. doi: 10.1038/s41420-024-02184-z.ABSTRACTFatty…
